The African In Vitro Diagnostics Industry is Expected to Reach $1.78 Billion by 2029 at a CAGR of 4.8%
2023-02-10
诊断试剂
DUBLIN, Feb. 10, 2023 /PRNewswire/ -- The "Africa In Vitro Diagnostics Market by Product & Services, Technology, Application, Diagnostic Approach, Customer Type - Forecast to 2029" report has been added to
ResearchAndMarkets.com's offering.
The Africa IVD market is expected to grow at a CAGR of 4.8% from 2022 to 2029 to reach $1.78 billion by 2029.
Companies Mentioned
Following a detailed secondary and primary research and an in-depth analysis of the market scenario, the report provides the key drivers, restraints, challenges, and opportunities in the Africa IVD market.
The high prevalence of infectious diseases, the rising burden of chronic diseases, the rising initiatives to support the healthcare sector, and the growing awareness about the importance of early disease diagnosis are the major drivers for the Africa IVD market. However, poor healthcare facilities and infrastructure in African countries are the major challenges to the market's growth.
Based on product category, in 2022, the reagents, assays, and kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the frequent use of assays & kits in the detection of various chronic diseases coupled with the high burden of infectious diseases in African countries.
Based on technology, in 2022, the immunoassay segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the advantages of immunoassays, such as simplicity, high accuracy standards, high throughput capability, and inherent specificity.
Based on application, in 2022, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region and the rising initiatives to boost testing capabilities.
Based on diagnostic approach, in 2022, the laboratory testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy offered by laboratory testing.
Based on customer type, in 2022, the hospital laboratories testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the higher preference for hospitals as the primary center of care.
Based on geography, in 2022, South Africa is expected to account for the largest share of this market. The major share of this region is mainly attributed to the high burden of diseases, the rising geriatric population, the increasing initiatives to promote diagnostic testing, and continuous efforts to develop healthcare infrastructure and promote awareness.
Scope of the Report:
Africa IVD Market, by Product Category
Reagents, Assays, and Kits
Instruments
Software & Services
Africa IVD Market, by Technology
Immunoassay
Whole Blood Glucose Monitoring
Clinical Chemistry
Hematology
Coagulation & Hemostasis
Critical Care
Urinalysis
Other IVD Technologies
Africa IVD Market, by Application
Oncology
Endocrinology
Cardiology
Other Applications
Africa IVD Market, by Diagnostic Approach
Laboratory Testing
Point-of-Care Testing
OTC/Self-testing
Africa IVD Market, by Customer Type
Hospital Labs
Private Labs
Home Care/Self Testing
Government
Other Customer Types
Africa IVD Market, by Country
South Africa
Egypt
Nigeria
Kenya
Algeria
Tanzania
Morocco
Tunisia
Rest of Africa
For more information about this report visit https://www.researchandmarkets.com/r/n773ft-in-vitro?w=5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。